TrialNature medicine2022

Subcutaneous infusion of exenatide and cardiovascular outcomes in type 2 diabetes: a non-inferiority randomized controlled trial.

Christian T Ruff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.